EUTM file information

018650684

SOM BIOTECH


February 7, 2022

Trademark Summary

The trademark application SOM BIOTECH was filed by SOM INNOVATION BIOTECH, S.A., a corporation established under the laws of the Kingdom of Spain (the "Applicant"). The application was published for oppositions on March 6, 2022, and it was registered by office on June 13, 2022 without any oppositions.

It was designated 'Basic Application' for International Application 1696738 at the World Intellectual Property Organization (WIPO).

The application was filed in Spanish (English was selected as the second language).


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceuticals
    2. Pharmaceutical drugs
    3. Medicine
    4. Pharmaceutical preparations for veterinary use
    5. Pharmaceutical preparations for the prevention of disorders of the nervous system
    6. Pharmaceutical preparations for the prevention of diseases of the nervous system
    7. Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases
    8. Pharmaceutical preparations for treating metabolic disorders
    9. Chemical preparations for medical purposes
    10. Chemical preparations for pharmaceutical purposes
    11. Pharmaceutical agents affecting metabolism
    12. Pharmaceutical preparations for treating malignant tumors
    13. Pharmaceutical preparations for activating cellular function
    14. Medicines for the treatment of cardiovascular and cerebrovascular diseases
    15. Pharmaceutical preparations for the treatment of Parkinson's disease
    16. Pharmaceutical preparations for the prevention of disorders of the respiratory system
    17. Pharmaceutical preparations for the prevention of diseases of the respiratory system
    18. Pharmaceutical preparations for the treatment of rare diseases
    19. Pharmaceuticals, for use in the following fields: Treatment of hereditary diseases
    20. Pharmaceutical preparations for the treatment of gastro-intestinal disorders
    21. Pharmaceutical products for the treatment of infectious diseases
    22. Pharmaceuticals, for use in the following fields: Treatment of movement disorders
    23. Pharmaceutical preparations for use in oncology
    24. Pharmaceuticals for the treatment of immune system disease
    25. Pharmaceuticals, for use in the following fields: Treatment of skeletal muscular diseases
    26. Pharmaceuticals, for use in the following fields: Treatment of hormone disorders
    27. Pharmaceuticals, for use in the following fields: Treatment of skin diseases
    28. Pharmaceutical preparations for use in ophthalmology
    29. Pharmaceuticals, for use in the following fields: Treatment of gynaecological diseases
    30. Pharmaceuticals, for use in the following fields: Treatment of haematological diseases
    31. Pharmaceuticals, for use in the following fields: Treatment of paediatric diseases
    32. Drug delivery agents
    33. Drug detoxifying agents
    34. Central nervous system stimulants
    35. Respiratory stimulants
    36. Capsules for medicines
    37. Cardiovascular drugs used in treating congestive heart failure (CHF)
    38. Preparations for detecting genetic predispositions for medical purposes
    39. Reagents for use in medical genetic testing
    40. Clinical medical reagents: Cells for medical use
    41. Tumor suppressing agents
    42. Tumour antigens
    43. Biopharmaceuticals for the treatment of cancer.
  • The mark was filed in class 42 with following description of goods:
    1. Clinical research
    2. Biological research
    3. Chemical technological research
    4. Scientific research
    5. Biomedical research
    6. Research services in the fields of computation chemistry
    7. Medical and pharmacological research services
    8. Pharmaceutical research and development
    9. Research and development of vaccines and medicines
    10. Research relating to molecular sciences
    11. Research relating to biotechnology
    12. Genetic research
    13. Research and development in the field of microorganisms and cells
    14. Stem cell research
    15. Research in the field of artificial intelligence technology
    16. Research in relation to the following fields: artificial intelligence technology
    17. Pharmaceutical drug development services
    18. Development of pharmaceutical preparations and medicines
    19. Drug discovery services
    20. Implementation of preclinical trials
    21. Clinical research
    22. Clinical trials
    23. Clinical research
    24. Biotechnology testing
    25. Providing information about the results of clinical trials for pharmaceutical products
    26. Consultancy pertaining to pharmacology
    27. Consultancy relating to research in the field of pharmacogenetics
    28. Consultancy relating to pharmaceutical research and development
    29. Chemistry consultation
    30. Consultancy relating to biotechnology
    31. Information on the subject of scientific research in the field of biochemistry and biotechnology
    32. Analysis in the field of molecular biology
    33. Laboratory analysis in the field of chemistry
    34. Design and development of medical technology
    35. Information technology services for the pharmaceutical and healthcare industries
    36. Design and development of computer software for use with medical technology
    37. Design and development in relation to the following fields: artificial intelligence technology
    38. Drug repositioning research
    39. Drug combination research.